H. Tomioka

1.2k total citations
49 papers, 892 citations indexed

About

H. Tomioka is a scholar working on Molecular Biology, Mechanical Engineering and Electrical and Electronic Engineering. According to data from OpenAlex, H. Tomioka has authored 49 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Mechanical Engineering and 8 papers in Electrical and Electronic Engineering. Recurrent topics in H. Tomioka's work include Advancements in Photolithography Techniques (5 papers), Nanofabrication and Lithography Techniques (5 papers) and Photoreceptor and optogenetics research (4 papers). H. Tomioka is often cited by papers focused on Advancements in Photolithography Techniques (5 papers), Nanofabrication and Lithography Techniques (5 papers) and Photoreceptor and optogenetics research (4 papers). H. Tomioka collaborates with scholars based in Japan, United States and Sweden. H. Tomioka's co-authors include T. Masumoto, A. Inoue, Ryuichi Morishita, Hironori Nakagami, Munehisa Shimamura, Akiko Tenma, Akira Inoue, Hiroshi Koriyama, Hirohisa Saito and Hitomi Kurinami and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Applied Physics Letters.

In The Last Decade

H. Tomioka

49 papers receiving 860 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Tomioka Japan 16 312 236 168 139 90 49 892
K. Sikorski Poland 16 164 0.5× 182 0.8× 183 1.1× 197 1.4× 47 0.5× 43 784
Xiaojun Xie China 19 297 1.0× 324 1.4× 448 2.7× 135 1.0× 60 0.7× 61 1.1k
Jiuzhou Zhao China 18 268 0.9× 302 1.3× 331 2.0× 73 0.5× 150 1.7× 62 1.5k
John T. Norton United States 18 200 0.6× 329 1.4× 135 0.8× 60 0.4× 79 0.9× 48 907
Koichi Niwa Japan 20 68 0.2× 222 0.9× 213 1.3× 110 0.8× 151 1.7× 101 1.3k
K.I. Vasu India 12 157 0.5× 303 1.3× 158 0.9× 36 0.3× 27 0.3× 47 734
Anindita Bhattacharya India 14 156 0.5× 169 0.7× 94 0.6× 116 0.8× 88 1.0× 63 762
Bin Tian China 21 165 0.5× 313 1.3× 306 1.8× 44 0.3× 140 1.6× 41 1.1k
Maho Yamaguchi Japan 18 174 0.6× 276 1.2× 394 2.3× 71 0.5× 193 2.1× 27 926
Yusuke Niwa Japan 22 106 0.3× 561 2.4× 342 2.0× 172 1.2× 161 1.8× 57 1.6k

Countries citing papers authored by H. Tomioka

Since Specialization
Citations

This map shows the geographic impact of H. Tomioka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Tomioka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Tomioka more than expected).

Fields of papers citing papers by H. Tomioka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Tomioka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Tomioka. The network helps show where H. Tomioka may publish in the future.

Co-authorship network of co-authors of H. Tomioka

This figure shows the co-authorship network connecting the top 25 collaborators of H. Tomioka. A scholar is included among the top collaborators of H. Tomioka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Tomioka. H. Tomioka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Eun‐Seo, Yasuhiro Suzuki, H. Tomioka, Hironori Nakagami, & Yasufumi Sato. (2023). Development of a Novel and Simple Anti-Metastatic Cancer Treatment Targeting Vasohibin-2. The Tohoku Journal of Experimental Medicine. 261(3). 239–247. 2 indexed citations
2.
Hayashi, Hiroki, Jiao Sun, Shota Yoshida, et al.. (2023). Peptide-based vaccine targeting IL17A attenuates experimental spondyloarthritis in HLA-B27 transgenic rats. RMD Open. 9(1). e002851–e002851. 4 indexed citations
3.
Yoshida, Shota, Hironori Nakagami, Hiroki Hayashi, et al.. (2020). The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice. Nature Communications. 11(1). 2482–2482. 106 indexed citations
4.
Suda, Hiroyuki, Akihiko Murakami, Toshihiro Kaga, H. Tomioka, & Ryuichi Morishita. (2014). Beperminogene perplasmid for the treatment of critical limb ischemia. Expert Review of Cardiovascular Therapy. 12(10). 1145–1156. 13 indexed citations
5.
Tomioka, H., Hironori Nakagami, Akiko Tenma, et al.. (2014). Novel Anti-Microbial Peptide SR-0379 Accelerates Wound Healing via the PI3 Kinase/Akt/mTOR Pathway. PLoS ONE. 9(3). e92597–e92597. 46 indexed citations
6.
Tomioka, H., Hironori Nakagami, Kazuaki Takafuji, et al.. (2014). Development of LC-MS/MS Quantification of the Novel Antimicrobial Peptide, SR-0379, and its Pharmacokinetics in Rats. Immunology Endocrine & Metabolic Agents - Medicinal Chemistry. 14(1). 26–31. 1 indexed citations
7.
Shimamura, Munehisa, Yoshiaki Taniyama, Hironori Nakagami, et al.. (2014). Long-term expression of periostin during the chronic stage of ischemic stroke in mice. Hypertension Research. 37(6). 494–499. 16 indexed citations
8.
Nakagami, Hironori, Hiroshi Koriyama, H. Tomioka, et al.. (2013). Development of novel DNA vaccine for VEGF in murine cancer model. Scientific Reports. 3(1). 3380–3380. 15 indexed citations
9.
Nakagami, Hironori, Hiroshi Koriyama, Futoshi Nakagami, et al.. (2013). Inhibition of Neointima Formation through DNA Vaccination for Apolipoprotein(a): A New Therapeutic Strategy for Lipoprotein(a). Scientific Reports. 3(1). 1600–1600. 6 indexed citations
10.
Tran, Quang‐Kim, Hiroshi Watanabe, Kazuhiko Takeuchi, et al.. (2001). Insulin Inhibits Coronary Endothelial Cell Calcium Entry and Coronary Artery Relaxation. Journal of Cardiovascular Pharmacology. 38(6). 885–892. 2 indexed citations
11.
Tomioka, H., H. Yoshizawa, Kiyofumi Suzuki, et al.. (1998). Electrical Resistivity of High Purity Chromium Single Crystal. physica status solidi (a). 167(2). 443–448. 1 indexed citations
12.
Yamaguchi, Ichirou, et al.. (1996). Real-time image processing using polarization discrimination of bacteriorhodopsin. Synthetic Metals. 81(2-3). 147–149. 11 indexed citations
13.
Otomo, Jun, Yuji Urabe, H. Tomioka, & Hisahiro Sasabe. (1992). The primary structures of helices A to G of three new bacteriorhodopsin-like retinal proteins. Journal of General Microbiology. 138(11). 2389–2396. 20 indexed citations
14.
Tomioka, H., et al.. (1989). A New Reliability Problem Associated with Ar Ion Sputter Cleaning of Interconnect Vias. Reliability physics. 53–58. 5 indexed citations
15.
Liu, J., H. Tomioka, L. Arnberg, & S. J. Savage. (1989). Improved corrosion resistance in silicon-alloyed stainless steel wires by rapid solidification. Materials Letters. 8(9). 381–384. 2 indexed citations
16.
17.
Inoue, A., H. Tomioka, & T. Masumoto. (1985). Microstructure and mechanical properties of Fe-Ni-Cr-Al steel wires produced by in-rotating-water spinning method. Metallurgical Transactions A. 16(2). 215–226. 7 indexed citations
18.
Inoue, A., H. Tomioka, & T. Masumoto. (1983). Mechanical properties of ductile Fe-Ni-Zr and Fe-Ni-Zr (Nb or Ta) amorphous alloys containing fine crystalline particles. Journal of Materials Science. 18(1). 153–160. 78 indexed citations
19.
Tomioka, H., H. Kitagawa, & Yasuji Izawa. (1979). ChemInform Abstract: PHOTOLYSIS OF N,N‐DIETHYLDIAZOACETAMIDE. PARTICIPATION OF A NONCARBENIC PROCESS IN INTRAMOLECULAR CARBON‐HYDROGEN INSERTION. Chemischer Informationsdienst. 10(52). 3 indexed citations
20.
Miura, Yukio, Kiyoshi Kobayashi, H. Sakuma, et al.. (1978). Plasma Noradrenaline Concentrations and Haemodynamics in the Early Stage of Essential Hypertension. Clinical Science. 55(s4). 69s–71s. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026